Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydroquinolinones for medical treatment

Dihydroquinolinones for medical treatment

US Patent 12091397 · Granted Sep 17, 2024

Estimated economic value: $20,283,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triazatricycle compounds for the treatment of autoimmune disease2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseas2025
Isoindolinone and indazole compounds for the degradation of EGFR2025
EGFR inhibitors for the treatment of cancer2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Isoindolinone and indazole compounds for the degradation of EGFR2025
Dihydrobenzimidazolones for medical treatment2025
Dihydrobenzimidazolones for medical treatment2025
Dihydrobenzimidazolones for medical treatment2025
Dihydrobenzimidazolones for medical treatment2025
EGFR inhibitor for the treatment of cancer2025
Pyrazolopyridine compounds for the treatment of autoimmune disease2025